Lemaitre Vascular Inc (LMAT): George W Lemaitre , Chairman and CEO of Lemaitre Vascular Inc sold 110,189 shares on May 5, 2016. The Insider selling transaction was reported by the company on May 9, 2016 to the Securities and Exchange Commission. The shares were sold at $16.12 per share for a total value of $1,781,910.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 9, 2016, David B Roberts (President and Director) sold 17,064 shares at $15.89 per share price.On Dec 14, 2015, Joseph P Jr Pellegrino (Chief Financial Officer) sold 21,033 shares at $16.01 per share price.Also, On Dec 8, 2015, Peter R Gebauer (President, International OP) sold 12,816 shares at $15.53 per share price.On Nov 24, 2015, Cornelia W Lemaitre (director) sold 41,135 shares at $15.62 per share price.
Shares of LeMaitre Vascular Inc (LMAT) ended Friday, May 6, 2016 session in red amid volatile trading. The shares closed down -0.22 points or -1.36% at $15.95 with 72,075 shares getting traded. Post opening the session at $16.16, the shares hit an intraday low of $15.8 and an intraday high of $16.1742 and the price vacillated in this range throughout the day. The company has a market cap of $293 M and the number of outstanding shares has been calculated to be 1,83,39,704 shares. The 52-week high of LeMaitre Vascular Inc is $18.44 and the 52-week low is $9.1.
Company has been under the radar of several Street Analysts.LeMaitre Vascular Inc is Reiterated by Barrington Research to Outperform and the brokerage firm has raised the Price Target to $ 15.50 from a previous price target of $14 .The Rating was issued on Feb 25, 2016.
LeMaitre Vascular Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop manufacture and market medical devices and implants used primarily in the field of vascular surgery. The Company’s product lines include valvulotomes balloon catheters carotid shunts biologic patches biologic grafts radiopaque marking tape anastomotic clips remote endarterectomy devices laparoscopic cholecystectomy devices vascular grafts angioscopes and powered phlebectomy devices. The Company develops manufactures and markets vascular devices to address the needs of vascular surgeons. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart including the Expandable LeMaitre Valvulotome the Pruitt F3 Carotid Shunt VascuTape Radiopaque Tape and the XenoSure biologic patch.